| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Over the last 12 months, insiders at Unicycive Therapeutics, Inc. have bought $0 and sold $0 worth of Unicycive Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Unicycive Therapeutics, Inc. have bought $12,375 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,000 shares for transaction amount of $12,375 was made by Schiller Brigitte () on 2022‑05‑16.
| Increased Positions | 23 | +164.29% | 1M | +23.13% |
| Decreased Positions | 4 | -28.57% | 47,988 | -0.93% |
| New Positions | 14 | New | 342,387 | New |
| Sold Out Positions | 3 | Sold Out | 45,074 | Sold Out |
| Total Postitions | 33 | +135.71% | 6M | +22.2% |
| Vivo Capital, Llc | $11,151.00 | 8.52% | 1.79M | +652,901 | +57.42% | 2025-09-30 |
| Octagon Capital Advisors Lp | $6,230.00 | 4.76% | 1M | 0 | 0% | 2025-09-30 |
| Nantahala Capital Management, Llc | $5,851.00 | 4.47% | 939,202 | 0 | 0% | 2025-09-30 |
| Great Point Partners I Lp | $4,963.00 | 3.79% | 796,558 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $4,105.00 | 3.14% | 658,878 | +52,925 | +8.73% | 2025-09-30 |
| Logos Global Management Lp | $2,950.00 | 2.26% | 473,563 | +<1 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $783.00 | 0.6% | 125,727 | +66,941 | +113.87% | 2025-09-30 |
| Squarepoint Ops Llc | $731.00 | 0.56% | 117,327 | +117,327 | New | 2025-09-30 |
| Acuta Capital Partners, Llc | $374.00 | 0.29% | 59,985 | -2,914 | -4.63% | 2025-09-30 |
| State Street Corp | $342.00 | 0.26% | 54,827 | +42,304 | +337.81% | 2025-09-30 |